📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes. (2022)

First Author: Mayne KJ

Attributed to: Adiposity and kidney disease: observations from large blood-based prospective cohorts across a wide range of different populations funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7326/j22-0029

PubMed Identifier: 35500259

Publication URI: http://europepmc.org/abstract/MED/35500259

Type: Journal Article/Review

Volume: 175

Parent Publication: Annals of internal medicine

Issue: 5

ISSN: 0003-4819